VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BMYBristol-Myers Squibb Company
$57.52$117.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBMYQuarterly Financials

Bristol-Myers Squibb Company (BMY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Bristol-Myers Squibb Company (BMY) quarterly income statement — complete revenue, gross profit & net income history

BMY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue11.49B12.5B12.22B12.27B11.2B12.34B11.89B12.2B11.87B11.48B10.97B11.23B
Revenue Growth %2.57%1.3%2.77%0.56%-5.6%7.54%8.44%8.69%4.66%0.62%-2.25%-5.56%
Cost of Goods Sold3.42B4.1B3.44B4.2B3.86B4.92B5.28B5.4B5.28B4.99B4.75B5.1B
COGS % of Revenue29.78%32.77%28.11%34.22%34.47%39.85%44.36%44.26%44.46%43.43%43.28%45.4%
Gross Profit8.07B8.4B8.79B8.07B7.34B7.42B6.62B6.8B6.59B6.49B6.22B6.13B
Gross Margin %70.22%67.23%71.89%65.78%65.53%60.15%55.64%55.74%55.54%56.57%56.72%54.6%
Gross Profit Growth %9.92%13.21%32.79%18.66%11.38%14.36%6.38%10.96%1.14%0.03%-3.52%-9.77%
Operating Expenses4.8B6.99B5.15B3.95B3.82B4.89B4.33B4.22B5.05B4.54B4.12B4.19B
OpEx % of Revenue41.75%55.88%42.12%32.22%34.1%39.65%36.4%34.56%42.6%39.56%37.53%37.29%
Selling, General & Admin1.62B2.18B1.79B1.69B1.58B1.85B1.98B1.92B2.36B2.06B1.94B1.93B
SG&A % of Revenue14.07%17.45%14.64%13.78%14.13%15.01%16.62%15.75%19.9%17.98%17.67%17.17%
Research & Development2.65B2.59B2.53B2.26B2.24B2.79B2.35B2.29B2.69B2.48B2.18B2.26B
R&D % of Revenue23.06%20.68%20.68%18.44%19.96%22.59%19.79%18.81%22.71%21.57%19.86%20.11%
Other Operating Expenses1000K1000K1000K001000K000000
Operating Income3.27B1.42B3.64B4.12B3.52B2.53B2.29B2.58B1.53B1.95B2.1B1.94B
Operating Margin %28.47%11.35%29.77%33.56%31.43%20.51%19.24%21.18%12.94%17.01%19.19%17.31%
Operating Income Growth %-7.1%-43.94%59.05%59.33%129.38%29.66%8.75%32.99%-37.42%13.89%-5.65%-27.74%
EBITDA3.71B2.25B4.63B5.15B4.53B4.41B4.88B5.18B4.07B4.42B4.54B4.38B
EBITDA Margin %32.27%17.96%37.9%41.94%40.47%35.74%41.04%42.46%34.28%38.48%41.39%38.97%
EBITDA Growth %-18.2%-49.1%-5.08%-0.66%11.46%-0.11%7.51%18.4%-16.69%4.27%-5.79%-17.01%
D&A (Non-Cash Add-back)437M826M993M1.03B1.01B1.88B2.59B2.6B2.53B2.46B2.44B2.43B
EBIT3.27B1.37B3.59B2.26B3.46B671M2.18B1.81B-11.09B1.99B2.4B2.14B
Net Interest Income0-51M-319M-346M-494M-496M-505M-521M-425M-316M-280M-282M
Interest Income00161M139M00000000
Interest Expense051M480M485M494M496M505M521M425M316M280M282M
Other Income/Expense-31M51M-525M-2.34B-550M-2.36B-612M-1.3B-13.05B-278M33M-84M
Pretax Income3.24B1.47B3.11B1.77B2.97B175M1.68B1.29B-11.52B1.67B2.14B1.86B
Pretax Margin %28.2%11.76%25.48%14.45%26.52%1.42%14.09%10.54%-97.06%14.59%19.49%16.56%
Income Tax561M384M919M460M509M99M461M-398M392M-88M203M-218M
Effective Tax Rate %17.31%26.12%29.51%25.94%17.13%56.57%27.51%-30.95%-3.4%-5.26%9.5%-11.73%
Net Income2.68B1.09B2.2B1.31B2.46B72M1.21B1.68B-11.91B1.76B1.93B2.07B
Net Margin %23.31%8.69%18.01%10.68%21.93%0.58%10.18%13.77%-100.39%15.35%17.58%18.47%
Net Income Growth %9.04%1408.33%81.75%-22.02%120.62%-95.91%-37.19%-18.96%-626.57%-12.86%20.05%45.88%
Net Income (Continuing)2.68B1.09B2.19B1.31B2.46B76M1.22B1.68B-11.91B1.76B1.93B2.08B
Discontinued Operations000000000000
Minority Interest34M33M48M54M59M53M58M54M58M55M64M57M
EPS (Diluted)1.310.531.080.641.200.040.600.83-5.890.870.930.99
EPS Growth %9.17%1401.42%80%-22.89%120.37%-95.94%-35.48%-16.16%-650.47%-8.42%24%50%
EPS (Basic)1.310.531.080.641.210.040.600.83-5.890.870.940.99
Diluted Shares Outstanding2.04B2.04B2.04B2.04B2.04B2.04B2.03B2.03B2.02B2.03B2.06B2.1B
Basic Shares Outstanding2.04B2.04B2.04B2.04B2.03B2.03B2.03B2.03B2.02B2.03B2.06B2.09B
Dividend Payout Ratio47.91%116.21%57.38%96.34%51.22%1691.67%100.41%72.44%-65.83%61.77%57.74%